Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Cardiology Cardiac Emergency

Cardiac Emergency

Is heart failure a risk factor for cancer?

The causal effect of cancer and cancer therapies on the development of heart failure is well known, but what about the other way around? Explore the evidence for the pathophysiological pathways linking tumor growth with heart failure.

Read more

Editor's Choice

Bone cement leakage causes intracardiac foreign bodies and PE

Patient presenting with chest tightness and dyspnea after surgery for thoracolumbar vertebral compression fracture. Multi-organ embolism was identified caused by bone cement leakage. 

OGTT superior for cardiovascular risk prediction in people with CAD

Two-hour post-load glucose is better at detecting dysglycemia and predicting cardiovascular events than HbA1c in patients with coronary artery disease.

Guidelines: neurological care for ECMO patients

  • Open Access
  • ECMO
  • Review

Patients receiving extracorporeal membrane oxygenation commonly experience major complications, including acute brain injury. How should you monitor these patients to prevent ABI, and manage ABI if it occurs?

MRAs benefit HF patients across ejection fraction phenotypes

Mineralocorticoid receptor antagonists could benefit patients with heart failure across the spectrum of ejection fraction phenotypes.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Latest News

More good news for aficamten in obstructive HCM

A role for ICDs in Chagas cardiomyopathy?

OGTT superior for cardiovascular risk prediction in people with CAD

De-escalating from DAPT to ticagrelor monotherapy does not increase ischemic risk after PCI

MRAs benefit HF patients across ejection fraction phenotypes

Semaglutide reduces obesity-related MACE risk despite kidney impairment

Case Studies

Bone cement leakage causes intracardiac foreign bodies and PE

Patient presenting with chest tightness and dyspnea after surgery for thoracolumbar vertebral compression fracture. Multi-organ embolism was identified caused by bone cement leakage. 

MI masking as wrist pain in a young man

A 41-year-old man presented with severe hand and wrist pain in both hands, and mild epigastric pain. An ECG showed anterior STEMI with an ejection fraction of 35–40%. Angiography showed severe left anterior descending artery and first obtuse marginal artery stenosis.

Aortic arch pathology with a shaggy aorta

Co-presentation of aortic aneurysms and a shaggy aorta carry catastrophic risks of brain infarction and spinal cord injury. Follow the surgical approach taken in this high-risk case.

Episode 3: Unravelling resistant hypertension

Why is it so difficult to diagnose and manage?

Resistant hypertension is a difficult to treat and often misunderstood phenomenon that continues to frustrate cardiologists. 

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options.

Prof. Morris Brown
Prof. Bryan Williams
Listen now

Current Reviews

Myocardial Scar Imaging: Viability Beyond REVIVED

Coronary artery disease (CAD) is the most common cause of heart failure worldwide, with several studies evaluating the role of revascularisation on mortality in patients with CAD and heart failure [ 1 ]. The landmark Surgical Treatment for …

The Multifaceted Roles of Hippo-YAP in Cardiovascular Diseases

The Hippo-yes-associated protein (YAP) signaling pathway plays a crucial role in cell proliferation, differentiation, and death. It is known to have impact on the progression and development of cardiovascular diseases (CVDs) as well as in the …

Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis

Hyperuricemia has been associated with an increased incidence of cardiovascular diseases, including coronary artery disease (CAD) [ 1 – 3 ], heart failure (HF) [ 4 ], atrial fibrillation (AF) [ 5 , 6 ], and hypertension [ 7 ], in addition to an …

The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices

Despite steady improvements in the management of acute cardiovascular conditions, cardiogenic shock (CS) continues to be a leading cause of morbidity and mortality [ 1 , 2 ]. CS is characterized by primary pump failure that leads to hypotension …

Keynote webinar | Spotlight on cardio-oncology

  • Webinar | 16-05-2023 | 17:30 (CEST)

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Watch now

Further Reading

Myocardial Scar Imaging: Viability Beyond REVIVED

Coronary artery disease (CAD) is the most common cause of heart failure worldwide, with several studies evaluating the role of revascularisation on mortality in patients with CAD and heart failure [ 1 ]. The landmark Surgical Treatment for …

National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021

Atherosclerotic cardiovascular diseases (ASCVDs) are the leading cause of morbidity and mortality in the USA, with an estimated 800,000 Americans suffering a myocardial infarction (MI) event annually [ 1 ]. The burden accounts for one in four …

Anti-inflammatory effects of proprotein convertase subtilisin/kexin 9 inhibitor therapy in the early phase of acute myocardial infarction

This study examined the anti-inflammatory and endothelial function-enhancing effects of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitor therapy in the early phase after acute myocardial infarction (AMI) by assessing changes in tumor …

Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study

  • Open Access
  • Diabetes
  • Original Research

Acute myocardial infarction (AMI) is the leading cause of mortality globally [ 1 ], with the incidence of non-ST segment myocardial infarction (NSTEMI), in particular, increasing [ 2 ]. Diabetes mellitus is an important risk factor for NSTEMI, with …

Related topics

Is heart failure a risk factor for cancer?

The causal effect of cancer and cancer therapies on the development of heart failure is well known, but what about the other way around? Explore the evidence for the pathophysiological pathways linking tumor growth with heart failure.

Read more

OGTT superior for cardiovascular risk prediction in people with CAD

Semaglutide reduces obesity-related MACE risk despite kidney impairment

A promising new factor XIa inhibitor?

Noise pollution dangerous for heart health

CV risk lower in women with familial hypercholesterolemia than men

Image Credits